Comprehensive medication guide to Syeda 28 Day including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Estimated Insurance Pricing
$0 copay under most ACA-compliant health plans (contraceptive mandate); Tier 1–2 generic on most formularies. Some high-deductible plans may charge a copay of $5–$30 until the deductible is met.
Estimated Cash Pricing
$92–$147 retail price for a 28-tablet pack without insurance; as low as $8–$26 with GoodRx or SingleCare discount cards at participating pharmacies for a 28-day supply.
Medfinder Findability Score
78/100
Summarize with AI
On this page
Syeda 28 Day is a combination oral contraceptive (birth control pill) containing two synthetic hormones: drospirenone (3 mg) and ethinyl estradiol (0.03 mg). It is a generic equivalent of the brand-name pill Yasmin, originally made by Bayer and first approved in the United States in 2001. Syeda was launched as a generic by Sandoz in 2011 and is currently manufactured by Laboratorios Leon Farma in Spain and marketed by Xiromed.
Each 28-day blister pack contains 21 yellow active tablets (each with drospirenone 3mg and ethinyl estradiol 0.03mg) and 7 white inert placebo tablets. Patients take one tablet daily at the same time each day. Syeda is FDA-approved for the prevention of pregnancy and is also commonly prescribed off-label for moderate acne, premenstrual dysphoric disorder (PMDD), and dysmenorrhea.
Drospirenone is a fourth-generation progestin with two distinctive properties beyond contraception: antiandrogenic activity (helps with acne and excess androgen effects) and antimineralocorticoid activity (counteracts estrogen-related water retention and bloating, similar to the mechanism of spironolactone).
We have a 99% success rate finding medications, even during nationwide shortages.
Need this medication?
Syeda 28 Day prevents pregnancy through three complementary mechanisms. The primary mechanism is suppression of ovulation: the synthetic estrogen (ethinyl estradiol) and progestin (drospirenone) act on the hypothalamic-pituitary axis, inhibiting the FSH and LH surges necessary for follicle development and egg release. Without ovulation, fertilization cannot occur.
As secondary mechanisms, Syeda thickens cervical mucus — creating a physical barrier that impedes sperm entry into the uterus — and thins the uterine lining (endometrium), making implantation unlikely even if breakthrough ovulation were to occur. Together, these three mechanisms provide robust contraceptive protection with a typical-use failure rate of approximately 9% per year and a perfect-use failure rate of less than 1% per year.
Drospirenone's additional properties make Syeda especially beneficial for patients with hormone-sensitive conditions. Its antiandrogenic activity reduces free androgens, improving acne and hirsutism. Its antimineralocorticoid activity (via spironolactone-like receptor binding) reduces aldosterone-driven fluid retention, minimizing the bloating sometimes seen with estrogen-containing pills.
3 mg / 0.03 mg — tablet (28-day pack)
21 active yellow tablets (drospirenone 3mg / ethinyl estradiol 0.03mg) + 7 white inert placebo tablets. Take one tablet daily by mouth at the same time each day.
Syeda 28 Day is generally available at U.S. pharmacies and is not listed on the FDA's active drug shortage database as of 2026. However, pharmacy-level stockouts are a real and common experience for patients. Because multiple therapeutically equivalent generics of Yasmin exist (Ocella, Zarah, Zumandimine, Syeda), chain pharmacies typically contract with a preferred generic supplier — and Syeda may not be their first choice, leading to intermittent unavailability at specific locations.
Syeda is manufactured in Spain by Laboratorios Leon Farma, which means international supply chain variability can occasionally affect U.S. pharmacy stock before any national shortage is formally declared. Patients in areas with high oral contraceptive demand or limited pharmacy choices may experience more frequent stockouts.
If you're having trouble finding Syeda in stock, medfinder calls pharmacies near you to check which ones can fill your prescription and texts you the results — saving hours of hold time and pharmacy visits.
Syeda 28 Day is not a controlled substance and carries no DEA scheduling restrictions. Any licensed prescriber can write a prescription for it, including via telehealth platforms in all 50 states. The following providers routinely prescribe Syeda and other combination oral contraceptives:
Obstetricians/Gynecologists (OB/GYNs) — the most common prescribers; specialists in reproductive health
Primary Care Physicians (PCPs) — family medicine and internal medicine doctors routinely prescribe COCs
Nurse Practitioners (NPs) and Physician Assistants (PAs) — can prescribe independently in most states; increasingly the primary contraceptive prescribers in community health settings
Certified Nurse Midwives (CNMs) — provide full reproductive healthcare including contraception
Telehealth platforms such as Nurx, The Pill Club, Hims & Hers, and Wisp can prescribe Syeda (or its therapeutic equivalents) after a virtual consultation or online questionnaire — and can route the prescription directly to a local pharmacy or ship it by mail. No in-person visit is required for most patients.
No. Syeda 28 Day is not a controlled substance and carries no DEA schedule. It can be prescribed by any licensed prescriber — including OB/GYNs, primary care physicians, nurse practitioners, and physician assistants — without special DEA registration or prescribing restrictions.
Because it is not scheduled, Syeda prescriptions can be called in, faxed, or sent electronically without the additional steps required for controlled substances. Refills are permitted, and telehealth providers can prescribe Syeda in all 50 states without any special restrictions. Patients do not need an in-person visit for a refill at most practices, and many telehealth services offer online prescribing with pharmacy delivery or electronic prescription routing.
Most side effects of Syeda are mild and resolve within the first 2–3 months of use. Common side effects include:
Nausea (most common in the first few weeks; take with food or at bedtime)
Breakthrough bleeding or spotting between periods
Breast tenderness or swelling
Headaches
Mood changes or decreased libido
Contact lens discomfort
Serious side effects requiring medical attention include:
Blood clots (deep vein thrombosis, pulmonary embolism) — seek emergency care for chest pain, leg swelling, or shortness of breath
Stroke or heart attack — seek emergency care for sudden headache, vision loss, or chest pain
Hyperkalemia (high potassium) — risk is higher in patients on ACE inhibitors, ARBs, or potassium-sparing diuretics
Elevated blood pressure
Liver damage (jaundice — discontinue immediately)
Know what you need? Skip the search.
Ocella
FDA AB-equivalent generic of Yasmin; identical drospirenone 3mg/EE 0.03mg formula. Most widely stocked Yasmin generic — can usually be dispensed without a new prescription.
Zarah
Another FDA AB-equivalent generic of Yasmin; same dose as Syeda. Good availability at major chains and mail-order pharmacies.
Yaz (Loryna, Nikki, Gianvi)
Drospirenone 3mg / EE 0.02mg — slightly lower estrogen dose; 24/4 schedule. FDA-approved for PMDD and acne in addition to contraception. Widely available generics.
Sprintec (norgestimate/EE)
Different progestin (norgestimate); extremely widely stocked. Lacks drospirenone's antiandrogenic and fluid-reducing benefits but highly available and affordable.
NuvaRing (etonogestrel/EE ring)
Monthly vaginal ring; eliminates daily pill requirement. Good option for patients who prefer fewer daily touchpoints and want to avoid oral contraceptive availability issues.
Prefer Syeda 28 Day? We can find it.
Rifampin
majorPotent CYP3A4 inducer — significantly reduces ethinyl estradiol levels and contraceptive effectiveness. Use backup contraception during rifampin treatment and for 28 days after.
St. John's Wort
majorCYP3A4 inducer herbal supplement — reduces EE levels and contraceptive efficacy. Avoid during Syeda use.
Ombitasvir/paritaprevir/ritonavir (Hep C)
majorContraindicated — causes significant ALT elevations. Do not co-administer.
Phenytoin / Carbamazepine / Barbiturates
majorEnzyme-inducing antiseizure medications reduce EE and progestin levels — use backup contraception.
ACE inhibitors / ARBs
moderateAdditive hyperkalemia risk with drospirenone's antimineralocorticoid activity. Check potassium in first treatment cycle.
Spironolactone / Potassium-sparing diuretics
moderateAdditive potassium-raising effect with drospirenone. Monitor serum potassium closely.
Lamotrigine
moderateSyeda significantly reduces lamotrigine plasma levels — may cause breakthrough seizures. Dose adjustment may be needed.
Thyroid hormone replacement (levothyroxine)
minorCOCs increase thyroid-binding globulin; may require levothyroxine dose adjustment.
Syeda 28 Day is a well-established, highly effective generic combination oral contraceptive with a unique pharmacological profile thanks to its drospirenone component. Its antiandrogenic and antimineralocorticoid properties make it a preferred option for patients with acne, excess androgen effects, or estrogen-related fluid retention — benefits that other generic birth control pills don't offer.
While not in a national shortage, Syeda can be difficult to find at specific pharmacies due to stocking preferences and its Spanish manufacturing origin. Patients who struggle to find it should ask about therapeutically equivalent alternatives (Ocella, Zarah) or use a search service to locate it in stock nearby. With insurance, most patients pay $0; without insurance, discount cards can bring the cost to under $30 per pack.
If you're having trouble finding Syeda 28 Day at your pharmacy, medfinder can call pharmacies near you to find which ones have it in stock — so you can get your prescription filled without the frustration.
Medfinder Editorial Standards
Our medication guides are researched and written to help patients make informed decisions. All content is reviewed for accuracy and updated regularly. Learn more about our standards